As described above, a prothrombotic status has been recognized in COVID-19 that can be at least partially explained by the already-mentioned induced endothelial dysfunction, the disproportionate inflammatory response but, also, to the reduced ACE2 expression induced by the SARS-Cov-2 infection [40]. The gene discussed is ACE2; the disease is endothelial dysfunction.